Competing cardiovascular and noncardiovascular risks and longevity in the systolic hypertension in the elderly program

American Journal of Cardiology

Volumn 113, Issue 4, 2014, Pages 676-681

  Kostis, William J ^a   Cabrera, Javier ^b,c   Messerli, Franz H ^d   Cheng, Jerry Q ^c   Sedjro, Jeanine E ^c   Cosgrove, Nora M ^c   Swerdel, Joel N ^c   Deng, Yingzi ^c   Davis, Barry R ^e   Kostis, John B ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d Columbia University College of Physicians and Surgeons ^*  (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATENOLOL; CARDIOVASCULAR DISEASES; CHLORTHALIDONE; FEMALE; HUMANS; HYPERTENSION; LONGEVITY; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84895072606     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.11.013     Document Type: Article

References (21)

1. F.H. Messerli, S. Bangalore, C. Torp-Pedersen, J.A. Staessen, and J.B. Kostis Cardiovascular drugs and cancer: of competing risk, small pox, Bernoulli and d'Alembert Eur Heart J 2013 1095 1098
2. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
3. J.B. Kostis, B.R. Davis, J. Cutler, R.H. Grimm Jr., K.G. Berge, J.D. Cohen, C.R. Lacy, H.M. Perry Jr., M.D. Blaufox, S. Wassertheil-Smoller, H.R. Black, E. Schron, D.M. Berkson, J.D. Curb, W.M. Smith, R. McDonald, W.B. Applegate for the SHEP Cooperative Research Group Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension JAMA 278 1997 212 216
4. J.B. Kostis, K.G. Berge, B.R. Davis, C.M. Hawkins, J. Probstfield for the SHEP Cooperative Research Group Effect of atenolol and reserpine on selected events in the Systolic Hypertension in the Elderly Program (SHEP) Am J Hypertens 8 1995 1147 1153
5. J.B. Kostis, J. Cabrera, J.Q. Cheng, N.M. Cosgrove, Y. Deng, S.L. Pressel, and B.R. Davis Association between chlorthalidone treatment of systolic hypertension and long-term survival JAMA 306 2011 2588 2593
6. R Development Core Team (2005). R: A Language and Environment for Statistical Computing, Reference Index Version 2.2.1. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
7. A. Beiser, R. D'Agostino, S. Seshadri, L. Sullivan, and P. Wolf Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro Stat Med 19 2000 1495 1522
8. J.J. Gaynor, E.J. Feuer, C. Tan, D.H. Wu, C.R. Little, D.J. Straus, B.D. Clarkson, and M.F. Brennan On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data J Am Stat Assoc 88 1993 400 409
9. D. Naimark, G. Naglie, and A.S. Detsky The meaning of life expectancy: what is a clinically significant gain? J Gen Intern Med 9 1994 702 707
10. J.C. Wright, and M.C. Weinstein Gains in life expectancy from medical interventions - standardizing data on outcomes N Engl J Med 339 1998 380 386
11. B. Efron Censored data and the bootstrap JASA 76 1981 312 319
12. K.M. Anderson, P.W. Wilson, P.M. Odell, and W.B. Kannel An updated coronary risk profile. A statement for health professionals Circulation 83 1991 356 362
13. J.B. Kostis, A.C. Wilson, R.S. Freudenberger, N.M. Cosgrove, S.L. Pressel, B.R. Davis for the SHEP Collaborative Research Group Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes Am J Cardiol 95 2005 29 35
14. J.M. Lachin Statistical properties of randomization in clinical trials Control Clin Trials 9 1988 289 311
15. J.B. Greenhouse, and M.M. Meyer A note on randomization and selection bias in maintenance therapy clinical trials Psychopharmacol Bull 27 1991 225 229
16. G. Holden, G. Rosenberg, K. Barker, S. Tuhrim, and B. Brenner The recruitment of research participants: a review Soc Work Health Care 19 1993 1 44
17. E. Barrett-Connor, and G.A. Laughlin Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials Semin Reprod Med 27 2009 275 282
18. J.R. Curtis, J.C. Larson, E. Delzell, M.A. Brookhart, S.M. Cadarette, R. Chlebowski, S. Judd, M. Safford, D.H. Solomon, and A.Z. Lacroix Placebo adherence, clinical outcomes, and mortality in the Women's Health Initiative randomized hormone therapy trials Med Care 49 2011 427 435
19. K. Meissner, U. Bingel, L. Colloca, T.D. Wager, A. Watson, and M.A. Flaten The placebo effect: advances from different methodological approaches J Neurosci 31 2011 16117 16124
20. The Coronary Drug Project Research Group Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project N Engl J Med 303 1980 1038 1041
21. D.M. Lloyd-Jones, D.O. Martin, M.G. Larson, and D. Levy Accuracy of death certificates for coding coronary heart disease as the cause of death Ann Intern Med 129 1998 1020 1026